BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16480339)

  • 1. Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major.
    Panethymitaki C; Bowyer PW; Price HP; Leatherbarrow RJ; Brown KA; Smith DF
    Biochem J; 2006 Jun; 396(2):277-85. PubMed ID: 16480339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
    Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
    J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites.
    Price HP; Menon MR; Panethymitaki C; Goulding D; McKean PG; Smith DF
    J Biol Chem; 2003 Feb; 278(9):7206-14. PubMed ID: 12488459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
    Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans.
    Lodge JK; Johnson RL; Weinberg RA; Gordon JI
    J Biol Chem; 1994 Jan; 269(4):2996-3009. PubMed ID: 8300631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes.
    Galvin BD; Li Z; Villemaine E; Poole CB; Chapman MS; Pollastri MP; Wyatt PG; Carlow CK
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3145. PubMed ID: 25188325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent.
    Lodge JK; Jackson-Machelski E; Higgins M; McWherter CA; Sikorski JA; Devadas B; Gordon JI
    J Biol Chem; 1998 May; 273(20):12482-91. PubMed ID: 9575206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode.
    Spinks D; Smith V; Thompson S; Robinson DA; Luksch T; Smith A; Torrie LS; McElroy S; Stojanovski L; Norval S; Collie IT; Hallyburton I; Rao B; Brand S; Brenk R; Frearson JA; Read KD; Wyatt PG; Gilbert IH
    ChemMedChem; 2015 Nov; 10(11):1821-36. PubMed ID: 26395087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the catalytic activities and substrate specificities of Saccharomyces cerevisiae myristoyl-coenzyme A: protein N-myristoyltransferase deletion mutants and human/yeast Nmt chimeras in Escherichia coli and S. cerevisiae.
    Rudnick DA; Johnson RL; Gordon JI
    J Biol Chem; 1992 Nov; 267(33):23852-61. PubMed ID: 1429724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
    Bayliss T; Robinson DA; Smith VC; Brand S; McElroy SP; Torrie LS; Mpamhanga C; Norval S; Stojanovski L; Brenk R; Frearson JA; Read KD; Gilbert IH; Wyatt PG
    J Med Chem; 2017 Dec; 60(23):9790-9806. PubMed ID: 29125744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of TbARL1, an N-myristoylated Golgi protein essential for viability in bloodstream trypanosomes.
    Price HP; Panethymitaki C; Goulding D; Smith DF
    J Cell Sci; 2005 Feb; 118(Pt 4):831-41. PubMed ID: 15687105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Candida albicans myristoyl-CoA:protein N-myristoyltransferase gene. Isolation and expression in Saccharomyces cerevisiae and Escherichia coli.
    Wiegand RC; Carr C; Minnerly JC; Pauley AM; Carron CP; Langner CA; Duronio RJ; Gordon JI
    J Biol Chem; 1992 Apr; 267(12):8591-8. PubMed ID: 1569105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myristoyl-CoA:protein N-myristoyltransferase depletion in trypanosomes causes avirulence and endocytic defects.
    Price HP; Güther ML; Ferguson MA; Smith DF
    Mol Biochem Parasitol; 2010 Jan; 169(1):55-8. PubMed ID: 19782106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
    Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF
    PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myristoyltransferase: a novel target.
    Prasad KK; Toraskar MP; Kadam VJ
    Mini Rev Med Chem; 2008 Feb; 8(2):142-9. PubMed ID: 18289097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Thienopyrimidine Inhibitors of
    Bell AS; Yu Z; Hutton JA; Wright MH; Brannigan JA; Paape D; Roberts SM; Sutherell CL; Ritzefeld M; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW
    J Med Chem; 2020 Jul; 63(14):7740-7765. PubMed ID: 32575985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
    Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
    Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the discovery of N-myristoyltransferase inhibitors.
    Zhao C; Ma S
    ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites.
    Olaleye TO; Brannigan JA; Roberts SM; Leatherbarrow RJ; Wilkinson AJ; Tate EW
    Org Biomol Chem; 2014 Nov; 12(41):8132-7. PubMed ID: 25230674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.